V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20026779 | 20011386 | 1.71 | 77.5 | Adjuvant (A) | 2017-04-06 | 2017-04-15 | FEC 100 + DOCETAXEL | null | null | 20094356 | FEC + DOCETAXEL |
| 20026780 | 20011387 | 1.57 | 89 | Adjuvant (A) | 2016-11-21 | 2016-11-24 | FEC + DOCETAXEL | 02 | null | 20094360 | FEC + DOCETAXEL |
| 20026781 | 20071720 | 1.75 | 132.5 | Curative (C) | 2014-08-24 | 2014-08-24 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20094365 | FEC + DOCETAXEL |
| 20026782 | 20011388 | 1.52 | 77.5 | Neo-adjuvant (N) | null | 2014-01-01 | FEC 100 + DOCETAXEL | N | N | 20094369 | FEC + DOCETAXEL |
| 20026783 | 20071721 | 1.62 | 93.5 | Adjuvant (A) | 2014-11-10 | 2014-11-18 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20094370 | FEC + DOCETAXEL |
| 20026784 | 20071721 | 1.65 | 59.9 | Adjuvant (A) | 2017-09-13 | 2017-09-15 | FEC 100 + DOCETAXEL | N | N | 20094370 | FEC + DOCETAXEL |
| 20026785 | 20011389 | null | null | Neo-adjuvant (N) | 2015-02-20 | 2015-03-07 | FEC + DOCETAXEL | N | null | 20094374 | FEC + DOCETAXEL |
| 20026786 | 20011389 | 1.62 | null | Adjuvant (A) | null | 2017-12-15 | FEC + DOCETAXEL | N | N | 20094374 | FEC + DOCETAXEL |
| 20026787 | 20011389 | 1.55 | 74.8 | Adjuvant (A) | null | 2016-09-20 | FEC 100 + DOCETAXEL | N | N | 20094374 | FEC + DOCETAXEL |
| 20026788 | 20011389 | 1.53 | 70 | Not known (9) | 2017-06-03 | 2017-06-22 | FEC 100 + DOCETAXEL | N | N | 20094374 | FEC + DOCETAXEL |
| 20026789 | 20011390 | 1.65 | 58.5 | Adjuvant (A) | 2016-02-12 | 2016-02-12 | FEC + DOCETAXEL | 02 | N | 20094384 | FEC + DOCETAXEL |
| 20026790 | 20011390 | 1.56 | 78.3 | Adjuvant (A) | 2013-12-31 | 2014-01-01 | FEC 100 + DOCETAXEL | 02 | N | 20094384 | FEC + DOCETAXEL |
| 20026791 | 20011391 | 1.63 | 80 | Adjuvant (A) | 2017-10-01 | 2017-10-03 | FEC + DOCETAXEL | 02 | N | 20094386 | FEC + DOCETAXEL |
| 20026792 | 20011391 | 1.67 | 100.4 | Adjuvant (A) | 2017-01-01 | 2017-01-06 | FEC 100 + DOCETAXEL | 02 | Y | 20094386 | FEC + DOCETAXEL |
| 20026793 | 20011392 | 1.61 | 50 | Adjuvant (A) | 2016-01-27 | 2016-02-08 | FEC + DOCETAXEL | N | N | 20094389 | FEC + DOCETAXEL |
| 20026794 | 20011392 | 1.68 | 65 | Adjuvant (A) | 2014-02-15 | 2014-02-24 | FEC 100 + DOCETAXEL | 02 | N | 20094389 | FEC + DOCETAXEL |
| 20026795 | 20011393 | null | 68.2 | Adjuvant (A) | 2015-09-27 | 2015-10-17 | FEC + DOCETAXEL | N | N | 20094406 | FEC + DOCETAXEL |
| 20026796 | 20011393 | 1.66 | null | Neo-adjuvant (N) | 2013-02-24 | 2013-03-25 | FEC + DOCETAXEL | Y | N | 20094406 | FEC + DOCETAXEL |
| 20026797 | 20011394 | 1.67 | 72.4 | Adjuvant (A) | 2014-05-18 | 2014-05-25 | FEC + DOCETAXEL | 02 | N | 20094412 | FEC + DOCETAXEL |
| 20026798 | 20011395 | 1.69 | 96 | Adjuvant (A) | 2016-05-17 | 2016-05-28 | FEC 60 OR 75 + DOCETAXEL | N | N | 20094426 | FEC + DOCETAXEL |
| 20026799 | 20071727 | 1.54 | 60 | Not known (9) | 2017-02-11 | 2017-02-12 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20094430 | FEC + DOCETAXEL |
| 20026800 | 20071727 | 1.55 | 100.65 | Adjuvant (A) | 2013-09-26 | 2013-10-10 | FEC + DOCETAXEL | null | null | 20094430 | FEC + DOCETAXEL |
| 20026801 | 20071727 | null | null | Adjuvant (A) | null | 2017-08-09 | FEC 100 + DOCETAXEL | null | N | 20094430 | FEC + DOCETAXEL |
| 20026802 | 20011396 | 1.56 | 116.4 | Adjuvant (A) | 2013-11-18 | 2013-11-23 | FEC 100 + DOCETAXEL | 2 | N | 20094444 | FEC + DOCETAXEL |
| 20026803 | 20011397 | 1.63 | 67.5 | Neo-adjuvant (N) | 2016-11-03 | 2016-11-06 | FEC + DOCETAXEL | 2 | N | 20094447 | FEC + DOCETAXEL |
| 20026804 | 20071728 | 1.53 | 94 | Adjuvant (A) | 2014-09-08 | 2014-09-25 | FEC + DOCETAXEL | 02 | null | 20094455 | FEC + DOCETAXEL |
| 20026805 | 20011398 | 1.67 | 99.5 | Neo-adjuvant (N) | 2016-04-08 | 2016-04-08 | FEC + DOCETAXEL | 02 | N | 20094457 | FEC + DOCETAXEL |
| 20026806 | 20011398 | null | 66 | null | 2013-04-15 | 2013-04-24 | FEC 100 + DOCETAXEL | null | null | 20094457 | FEC + DOCETAXEL |
| 20026807 | 20011399 | null | null | Adjuvant (A) | 2017-01-21 | 2017-01-29 | FEC 100 + DOCETAXEL | N | N | 20094461 | FEC + DOCETAXEL |
| 20026808 | 20011399 | 1.74 | 89.9 | Adjuvant (A) | 2017-05-01 | 2017-05-01 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20094461 | FEC + DOCETAXEL |
| 20026809 | 20011399 | 1.59 | 86 | Adjuvant (A) | 2017-04-27 | 2017-04-28 | FEC + DOCETAXEL | 02 | Y | 20094461 | FEC + DOCETAXEL |
| 20026810 | 20011399 | 1.6 | 64.55 | Neo-adjuvant (N) | 2015-02-15 | 2015-02-16 | FEC + DOCETAXEL | 02 | N | 20094461 | FEC + DOCETAXEL |
| 20026811 | 20011400 | null | null | Curative (C) | 2015-06-18 | 2015-06-18 | FEC + DOCETAXEL | N | N | 20094473 | FEC + DOCETAXEL |
| 20026812 | 20011400 | 1.66 | 75.7 | Disease modification (D) | 2016-11-23 | 2016-12-26 | FEC + DOCETAXEL | N | N | 20094473 | FEC + DOCETAXEL |
| 20026813 | 20011401 | 1.58 | 63.4 | Adjuvant (A) | 2017-10-08 | 2017-10-19 | FEC 100 + DOCETAXEL | 2 | null | 20094475 | FEC + DOCETAXEL |
| 20026814 | 20071732 | 1.69 | 96.7 | Adjuvant (A) | 2017-04-28 | 2017-05-02 | FEC + DOCETAXEL | 02 | null | 20094481 | FEC + DOCETAXEL |
| 20026815 | 20071732 | 1.62 | 66 | Not known (9) | 2014-04-27 | 2014-05-22 | FEC 100 + DOCETAXEL | N | null | 20094481 | FEC + DOCETAXEL |
| 20026816 | 20127917 | 1.62 | 62.8 | Adjuvant (A) | 2013-10-17 | 2013-11-11 | FEC 100 + DOCETAXEL | N | N | 20094486 | FEC + DOCETAXEL |
| 20026817 | 20011402 | 1.71 | null | Neo-adjuvant (N) | 2013-05-04 | 2013-05-08 | FEC + DOCETAXEL | N | N | 20094492 | FEC + DOCETAXEL |
| 20026818 | 20011403 | 1.6 | 75.6 | Adjuvant (A) | 2016-12-14 | 2016-12-21 | FEC + DOCETAXEL | 02 | N | 20094496 | FEC + DOCETAXEL |
| 20026819 | 20011404 | 1.64 | 74 | Neo-adjuvant (N) | 2016-01-22 | 2016-02-10 | FEC + DOCETAXEL | 02 | null | 20094500 | FEC + DOCETAXEL |
| 20026820 | 20011404 | 1.64 | 67.7 | Adjuvant (A) | 2013-03-03 | 2013-03-11 | FEC + DOCETAXEL | 02 | N | 20094500 | FEC + DOCETAXEL |
| 20026821 | 20108828 | null | 63 | null | 2015-07-19 | 2015-07-30 | FEC + DOCETAXEL | N | null | 20094503 | FEC + DOCETAXEL |
| 20026822 | 20127918 | 1.6 | null | Adjuvant (A) | null | 2018-02-28 | FEC + DOCETAXEL | null | null | 20094506 | FEC + DOCETAXEL |
| 20026823 | 20127918 | 1.7 | null | Adjuvant (A) | 2017-09-14 | 2017-09-28 | FEC 100 + DOCETAXEL | N | N | 20094506 | FEC + DOCETAXEL |
| 20026825 | 20011406 | 1.6 | null | Adjuvant (A) | 2016-07-02 | 2016-07-16 | FEC + DOCETAXEL | N | null | 20094514 | FEC + DOCETAXEL |
| 20026826 | 20011407 | 1.57 | 97 | Adjuvant (A) | 2016-08-28 | 2016-08-28 | FEC + DOCETAXEL | 02 | N | 20094516 | FEC + DOCETAXEL |
| 20026827 | 20011407 | 1.71 | 80.5 | Adjuvant (A) | 2013-03-26 | 2013-03-26 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20094516 | FEC + DOCETAXEL |
| 20026828 | 20011408 | 1.6 | 97.4 | Neo-adjuvant (N) | 2016-05-14 | 2016-05-30 | FEC + DOCETAXEL | 2 | N | 20094529 | FEC + DOCETAXEL |
| 20026829 | 20011408 | null | 56.9 | Curative (C) | null | 2016-07-20 | FEC + DOCETAXEL | N | N | 20094529 | FEC + DOCETAXEL |